Are there any benefits of exercise training in cancer cachexia?

被引:100
作者
Argiles, Josep M. [1 ,2 ]
Busquets, Silvia [1 ,2 ]
Lopez-Soriano, Francisco J. [1 ,2 ]
Costelli, Paola [3 ]
Penna, Fabio [1 ,3 ]
机构
[1] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain
[2] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain
[3] Univ Turin, Dipartimento Med & Oncol Sperimentale, Turin, Italy
关键词
MUSCLE; MECHANISMS; SUPPORT; ANEMIA; MOUSE;
D O I
10.1007/s13539-012-0067-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Cancer cachexia is a complex syndrome characterized by inflammation, body weight loss, muscle, and adipose tissue wasting that is responsible for the death of a considerable percentage of cancer patients. In addition, during cachexia muscle strength and endurance are dramatically reduced, limiting the ability to perform daily activities and severely affecting the patient's quality of life. Different studies have emphasized that a single therapy may not be completely successful in the treatment of cachexia. Beyond pharmacological strategies, exercise training has been suggested as a promising countermeasure to prevent cachexia, in order to restore both strength and endurance, depending on the type of exercise. Unfortunately, a small number of studies, in both clinical and experimental settings, have been performed to date. Moreover, when considering exercise in cancer, several factors have to be taken into consideration, in particular those alterations that could limit the capacity to perform exercise and consequently the resulting beneficial or detrimental effects. This editorial is aimed at stimulating the debate on the suitability of including exercise training in a multi-functional approach against cachexia taking into consideration both limitations and advantages.
引用
收藏
页码:73 / 76
页数:4
相关论文
共 27 条
[1]  
Aagaard P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P165
[2]  
ARGILES JM, 1990, MED CLIN-BARCELONA, V94, P18
[3]  
Argiles JM, 1997, MED RES REV, V17, P477, DOI 10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.3.CO
[4]  
2-Q
[5]   Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse [J].
Aulino, Paola ;
Berardi, Emanuele ;
Cardillo, Veronica M. ;
Rizzuto, Emanuele ;
Perniconi, Barbara ;
Ramina, Carla ;
Padula, Fabrizio ;
Spugnini, Enrico P. ;
Baldi, Alfonso ;
Faiola, Fabio ;
Adamo, Sergio ;
Coletti, Dario .
BMC CANCER, 2010, 10
[6]   Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc Min/+ mouse [J].
Baltgalvis, Kristen A. ;
Berger, Franklin G. ;
Pena, Maria Marjorette O. ;
Davis, J. Mark ;
White, James P. ;
Carson, James A. .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2009, 457 (05) :989-1001
[7]   mTOR signaling and the molecular adaptation to resistance exercise [J].
Bodine, Sue C. .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2006, 38 (11) :1950-1957
[8]  
Bruera E, 2000, Lancet Oncol, V1, P138, DOI 10.1016/S1470-2045(00)00033-4
[9]  
Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO
[10]  
2-P